Duty to disclose to family members in medical genetics
β Scribed by Hecht, Frederick
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 82 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A patient who refuses to notify their relatives of potential atβrisk status brings a genetics provider to face conflicting ethical principles and illβdefined legal precedent. Genetics professionals' views on the disclosure of patient information to atβrisk relatives have remained largel
Estimation of parameters in a genetic model can be very difficult using likelihood theory when there is no concise functional form for the likelihood function. An alternative method bawd on fitting the characteristic function is suggested and this method may be used on data with consistent familial
Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant early-onset cancer disorder. In the Netherlands presymptomatic genetic testing for MEN 2 is offered to testees from the age of five years. We report on adults requesting testing for themselves (n=90) and on parents who want an at-r
Familial hypobetalipoproteinemia (FHBL) is an autosomal dominant disorder of lipid metabolism characterized by extremely low plasma levels of apolipoprotein B (apoB), and total-, and low-density lipoprotein (LDL) cholesterol. Various truncated forms of apoB have been found to cosegregate with the FH